{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T08:33:42Z","timestamp":1762590822337,"version":"build-2065373602"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,8]]},"DOI":"10.7759\/cureus.96352","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T08:30:20Z","timestamp":1762590620000},"source":"Crossref","is-referenced-by-count":0,"title":["Castleman Disease in a Child: A Rare Cause of Persistent Cervical Lymphadenopathy"],"prefix":"10.7759","author":[{"given":"Anupam","family":"Dutta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debajit","family":"Sarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranita","family":"Medhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankita","family":"Banik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh K","family":"Rabha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM195406102502308","article-title":"Case records of the Massachusetts General Hospital: case no. 40231","volume":"250","author":"Castleman B","year":"1954","unstructured":"Castleman B, Towne VW. Case records of the Massachusetts General Hospital: case no. 40231. N Engl J Med. 1954, 250:1001-5. 10.1056\/NEJM195406102502308","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2017.09.002","article-title":"Castleman disease pathogenesis","volume":"32","author":"Fajgenbaum DC","year":"2018","unstructured":"Fajgenbaum DC, Shilling D. Castleman disease pathogenesis. Hematol Oncol Clin North Am. 2018, 32:11-21. 10.1016\/j.hoc.2017.09.002","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1365-1","article-title":"Castleman\u2019s disease: systematic analysis of 416 patients from the literature","volume":"18","author":"Talat N","year":"2011","unstructured":"Talat N, Schulte KM. Castleman\u2019s disease: systematic analysis of 416 patients from the literature. Ann Surg Oncol. 2011, 18:297-305. 10.1245\/s10434-010-1365-1","journal-title":"Ann Surg Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.7.2331","article-title":"High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease","volume":"99","author":"Oksenhendler E","year":"2002","unstructured":"Oksenhendler E, Boulanger E, Galicier L, et al.. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood. 2002, 99:2331-6. 10.1182\/blood.v99.7.2331","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(16)00006-5","article-title":"Idiopathic multicentric Castleman's disease: a systematic literature review","volume":"3","author":"Liu AY","year":"2016","unstructured":"Liu AY, Nabel CS, Finkelman BS, et al.. Idiopathic multicentric Castleman's disease: a systematic literature review. Lancet Haematol. 2016, 3:e163-75. 10.1016\/S2352-3026(16)00006-5","journal-title":"Lancet Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70319-5","article-title":"Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial","volume":"15","author":"van Rhee F","year":"2014","unstructured":"van Rhee F, Wong RS, Munshi N, et al.. Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2014, 15:966-74. 10.1016\/S1470-2045(14)70319-5","journal-title":"Lancet Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-07-862334","article-title":"International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease","volume":"132","author":"van Rhee F","year":"2018","unstructured":"van Rhee F, Voorhees P, Dispenzieri A, et al.. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood. 2018, 132:2115-24. 10.1182\/blood-2018-07-862334","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318249dcdc","article-title":"Surgery in Castleman's disease: a systematic review of 404 published cases","volume":"255","author":"Talat N","year":"2012","unstructured":"Talat N, Belgaumkar AP, Schulte KM. Surgery in Castleman's disease: a systematic review of 404 published cases. Ann Surg. 2012, 255:677-84. 10.1097\/SLA.0b013e318249dcdc","journal-title":"Ann Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-12-545087","article-title":"HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy","volume":"123","author":"Fajgenbaum DC","year":"2014","unstructured":"Fajgenbaum DC, van Rhee F, Nabel CS. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood. 2014, 123:2924-33. 10.1182\/blood-2013-12-545087","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197203)29:3<670::aid-cncr2820290321>3.0.co;2-#","article-title":"Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations","volume":"29","author":"Keller AR","year":"1972","unstructured":"Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972, 29:670-83. 10.1002\/1097-0142(197203)29:3&lt;670::aid-cncr2820290321&gt;3.0.co;2-#","journal-title":"Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000931","article-title":"Overview of Castleman disease","volume":"135","author":"Dispenzieri A","year":"2020","unstructured":"Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease. Blood. 2020, 135:1353-64. 10.1182\/blood.2019000931","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-05-848671","article-title":"Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease","volume":"132","author":"Fajgenbaum DC","year":"2018","unstructured":"Fajgenbaum DC. Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease. Blood. 2018, 132:2323-30. 10.1182\/blood-2018-05-848671","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/419926-castleman-disease-in-a-child-a-rare-cause-of-persistent-cervical-lymphadenopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T08:30:21Z","timestamp":1762590621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/419926-castleman-disease-in-a-child-a-rare-cause-of-persistent-cervical-lymphadenopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,8]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.96352","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,8]]}}}